Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...

Research highlights the therapeutic potential of targeting cannabinoid receptors to counter memory impairment in early ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

Irritable bowel syndrome is the most common cause of chronic diarrhea and lower abdominal discomfort in North America.

the approval of COBENFY marks a transformative milestone as the first drug in over 30 years with a novel mechanism of action ...

KIST researchers discover treatment that halves hand tremors from nicotine withdrawal KIST scientists unveil innovative ...

A top doctor has revealed which common medications taken by millions could put you at risk of a heart attack. Dr Zain Hasan, an anesthetist in California, highlighted non-steroidal anti ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

This training course will guide you through the principles of safe prescribing and demonstrate how to complete the National Standard Medication Charts correctly. The course comprises of 5 modules: ...